BENZAZEPINONE CALCIUM-CHANNEL BLOCKERS .2. STRUCTURE-ACTIVITY AND DRUG-METABOLISM STUDIES LEADING TO POTENT ANTIHYPERTENSIVE AGENTS - COMPARISON WITH BENZOTHIAZEPINONES

被引：65
|
作者：
FLOYD, DM
KIMBALL, SD
KRAPCHO, J
DAS, J
TURK, CF
MOQUIN, RV
LAGO, MW
DUFF, KJ
LEE, VG
WHITE, RE
RIDGEWELL, RE
MORELAND, S
BRITTAIN, RJ
NORMANDIN, DE
HEDBERG, SA
CUCINOTTA, GG
机构：
[1] Bristol-Myers Squibb Pharmaceutical Research Institute, New Jersey 08543-4000, P.O. Box 4000, Princeton
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 1992年 / 35卷 / 04期
关键词：
D O I：
10.1021/jm00082a018
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
As part of a program to discover potent antihypertensive analogues of diltiazem (3a), we prepared 1-benzazepin-2-ones (4). Benzazepinones competitively displace radiolabeled diltiazem, and show the same absolute stereochemical preferences at the calcium channel receptor protein. Derivatives of 4 containing a trifluoromethyl substituent in the fused aromatic ring show potent and long-acting antihypertensive activity. Studies of the metabolism of 4 lead to the metabolically stable antihypertensive calcium channel blockers 5a and 5c. Benzazepinone 5a is a longer acting and more potent antihypertensive agent than the second generation diltiazem analogue TA-3090 (3e).
引用
收藏
页码：756 / 772
页数：17
相关论文
共 5 条
  • [1] PREPARATION AND STRUCTURE-ACTIVITY OF BASICALLY SUBSTITUTED 1,4-DIHYDROPYRIMIDINE CALCIUM-CHANNEL BLOCKERS - POTENT AND ORALLY EFFECTIVE ANTIHYPERTENSIVE AGENTS
    ROVNYAK, GC
    ATWAL, KS
    KIMBALL, SD
    OREILLY, BC
    SCHWARTZ, J
    MORELAND, S
    HEDBERG, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 200 : 112 - MEDI
  • [2] BENZAZEPINONE CALCIUM-CHANNEL BLOCKERS .3. SYNTHESIS AND STRUCTURE ACTIVITY STUDIES OF 3-ALKYLBENZAZEPINONES
    DAS, J
    FLOYD, DM
    KIMBALL, SD
    DUFF, KJ
    VU, TC
    LAGO, MW
    MOQUIN, RV
    LEE, VG
    GOUGOUTAS, JZ
    MALLEY, MF
    MORELAND, S
    BRITTAIN, RJ
    HEDBERG, SA
    CUCINOTTA, GG
    JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (04) : 773 - 780
  • [3] Structure-Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers
    Siegrist, Romain
    Pozzi, Davide
    Jacob, Gael
    Torrisi, Caterina
    Colas, Kilian
    Braibant, Bertrand
    Mawet, Jacques
    Pfeifer, Thomas
    de Kanter, Ruben
    Roch, Catherine
    Kessler, Melanie
    Corminboeuf, Olivier
    Bezencon, Olivier
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (23) : 10661 - 10675
  • [4] Structure Activity Relationship, Drug Metabolism and Pharmacokinetics Properties Optimization, and in Vivo Studies of New Brain Penetrant Triple T-Type Calcium Channel Blockers (vol 59, pg 10661, 2016)
    Siegrist, Romain
    Pozzi, Davide
    Jacob, Gael
    Torrisi, Caterina
    Colas, Kilian
    Braibant, Bertrand
    Mawet, Jacques
    Pfeifer, Thomas
    de Kanter, Ruben
    Roch, Catherine
    Kessler, Melanie
    Moon, Richard
    Corminboeuf, Olivier
    Bezencon, Olivier
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (05) : 2163 - 2163
  • [5] THEORETICAL-STUDIES APPLICABLE TO THE DESIGN OF NOVEL ANTICONVULSANTS .2. A COMPARISON OF AM1, MNDO, AND PM3 SEMIEMPIRICAL MOLECULAR-ORBITAL CONFORMATIONAL-ANALYSES OF DIHYDROPYRIDINE CALCIUM-CHANNEL BLOCKERS
    BIKKER, JA
    WEAVER, DF
    JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 1993, 100 (2-3): : 173 - 184
1